Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival

被引:17
作者
Fu, Yu-Fei [1 ]
Li, Yu [1 ]
Wei, Ning [2 ]
Xu, Hao [2 ]
机构
[1] Xuzhou Cent Hosp, Dept Radiol, 199 South Jiefang Rd, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Coll, Affiliated Hosp, Dept Intervent Radiol, 99 West Huai Hai Rd, Xuzhou, Jiangsu, Peoples R China
来源
RADIOLOGIA MEDICA | 2016年 / 121卷 / 07期
关键词
Interventional treatment; Chemotherapy; Lung cancer; Follow-up; Prognosis; QUALITY-OF-LIFE; NONSMALL CELL; RADIOFREQUENCY ABLATION; PRELIMINARY EXPERIENCE; SINGLE-CENTER; CHEMOTHERAPY; TUMORS; CARCINOMA; STENTS;
D O I
10.1007/s11547-016-0629-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To evaluate the long-term outcome and the predictor of survival in patients treated with transcatheter arterial chemical infusion for advanced non-small-cell lung cancer (NSCLC). From May 2008 to August 2014, a total of 40 consecutive patients with advanced NSCLC who underwent transcatheter arterial chemical infusion were enrolled in this retrospective study. Data on patients' characteristics, treatment response and follow-up were collected and analyzed. A total of 142 cycles of transcatheter arterial chemical infusion were administered to the 40 patients (3.55 cycles per case). In 21 patients, only the bronchial artery was the tumor feeding artery, while in the remaining 19 patients, other arteries in addition to the bronchial artery served as the tumor feeding arteries. Five patients underwent bronchial arterial embolization after transcatheter arterial chemical infusion. There was no serious procedure-related complication. During 1-60 months (mean 11.5 +/- 10.0 months) follow-up, 33 patients died. The objective response and disease control rates were 32.5 and 92.5 %, respectively. The mean time to tumor progression and overall survival was 9.2 +/- 1.4 and 13.1 +/- 2.0 months, respectively. Based on univariate and multivariate analyses, the independent predictors of decreasing overall survival were airway, esophagus, or superior vena cava involvement (P = 0.037) and more tumor feeding arteries in addition to the bronchial artery (P = 0.003). Transcatheter arterial chemical infusion is an easy and effective method for treating patients with advanced NSCLC and it can provide a favorable long-term outcome.
引用
收藏
页码:605 / 610
页数:6
相关论文
共 20 条
[1]   Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors [J].
Akhan, Okan ;
Guler, Ezgi ;
Akinci, Devrim ;
Ciftci, Turkmen ;
Kose, Ilgaz Cagatay .
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2016, 22 (01) :65-71
[2]   Microwave ablation of lung tumours: single-centre preliminary experience [J].
Carrafiello, Gianpaolo ;
Mangini, Monica ;
Fontana, Federico ;
Ierardi, Anna Maria ;
De Marchi, Giuseppe ;
Rotolo, Nicola ;
Chini, Claudio ;
Cuffari, Salvatore ;
Fugazzola, Carlo .
RADIOLOGIA MEDICA, 2014, 119 (01) :75-82
[3]   A systematic review of the impact of stigma and nihilism on lung cancer outcomes [J].
Chambers, Suzanne K. ;
Dunn, Jeffrey ;
Occhipinti, Stefano ;
Hughes, Suzanne ;
Baade, Peter ;
Sinclair, Sue ;
Aitken, Joanne ;
Youl, Pip ;
O'Connell, Dianne L. .
BMC CANCER, 2012, 12
[4]   Palliation of malignant esophageal obstruction and fistulas with self expandable metallic stents [J].
Dobrucali, Ahmet ;
Caglar, Erkan .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (45) :5739-5745
[5]   Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma [J].
Fan, Juan ;
Du, Jiangrong ;
Wu, Jingbo ;
Fu, Shaozhi ;
Hu, Defeng ;
Wan, Qiang .
ONCOLOGY LETTERS, 2015, 9 (02) :822-828
[6]   Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates [J].
Fernando, HC ;
De Hoyos, A ;
Landreneau, RJ ;
Gilbert, S ;
Gooding, WE ;
Buenaventura, PO ;
Christie, NA ;
Belani, C ;
Luketich, JD .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (03) :639-644
[7]  
Fu YF, 2014, DIAGN INTERV RADIOL, V20, P330, DOI [10.5152/dir.13498, 10.5152/dir.2014.13498]
[8]   The role of airway stent placement in the management of tracheobronchial stenosis caused by inoperable advanced lung cancer [J].
Furukawa, Kinya ;
Ishida, Junzo ;
Yamaguchi, Gaku ;
Usuda, Jitsuo ;
Tsutsui, Hidemitsu ;
Saito, Makoto ;
Konaka, Chimori ;
Kato, Harubumi .
SURGERY TODAY, 2010, 40 (04) :315-320
[9]   Tracheobronchial Stenting for Malignant Airway Disease: Long-Term Outcomes From a Single-Center Study [J].
Inchingolo, Riccardo ;
Sabharwal, Tarun ;
Spiliopoulos, Stavros ;
Krokidis, Mitiadis ;
Dourado, Renato ;
Ahmed, Irfan ;
King, Juliet ;
Adam, Andreas .
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2013, 30 (07) :683-689
[10]   Acute Superior Vena Cava Occlusion After Stenting of Tracheoesophageal Fistula [J].
Kapadia, Muneera R. ;
de Hoyos, Alberto L. ;
Blum, Matthew G. .
ANNALS OF THORACIC SURGERY, 2009, 87 (04) :1260-1262